Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neoantigen Targeted Therapies market report explains the definition, types, applications, major countries, and major players of the Neoantigen Targeted Therapies market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Gradalis
Genocea Biosciences
Iovance Biotherapeutics
Neon Therapeutics
Immunicum
Bavarian Nordic
Precision Biologics
Immunovative Therapies
Medigene
Vaxon Biotech
By Type:
Monotherapy
Combination Therapy
By End-User:
Medical Research Institution
Hospital and Clinic
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Neoantigen Targeted Therapies Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Neoantigen Targeted Therapies Outlook to 2028- Original Forecasts
-
2.2 Neoantigen Targeted Therapies Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Neoantigen Targeted Therapies Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Neoantigen Targeted Therapies Market- Recent Developments
-
6.1 Neoantigen Targeted Therapies Market News and Developments
-
6.2 Neoantigen Targeted Therapies Market Deals Landscape
7 Neoantigen Targeted Therapies Raw Materials and Cost Structure Analysis
-
7.1 Neoantigen Targeted Therapies Key Raw Materials
-
7.2 Neoantigen Targeted Therapies Price Trend of Key Raw Materials
-
7.3 Neoantigen Targeted Therapies Key Suppliers of Raw Materials
-
7.4 Neoantigen Targeted Therapies Market Concentration Rate of Raw Materials
-
7.5 Neoantigen Targeted Therapies Cost Structure Analysis
-
7.5.1 Neoantigen Targeted Therapies Raw Materials Analysis
-
7.5.2 Neoantigen Targeted Therapies Labor Cost Analysis
-
7.5.3 Neoantigen Targeted Therapies Manufacturing Expenses Analysis
8 Global Neoantigen Targeted Therapies Import and Export Analysis (Top 10 Countries)
-
8.1 Global Neoantigen Targeted Therapies Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Neoantigen Targeted Therapies Export by Region (Top 10 Countries) (2017-2028)
9 Global Neoantigen Targeted Therapies Market Outlook by Types and Applications to 2022
-
9.1 Global Neoantigen Targeted Therapies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Neoantigen Targeted Therapies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Research Institution Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital and Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Neoantigen Targeted Therapies Market Analysis and Outlook till 2022
-
10.1 Global Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.2.2 Canada Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.2.3 Mexico Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.2 UK Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.3 Spain Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.4 Belgium Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.5 France Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.6 Italy Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.7 Denmark Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.8 Finland Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.9 Norway Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.10 Sweden Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.11 Poland Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.12 Russia Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.3.13 Turkey Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.2 Japan Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.3 India Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.4 South Korea Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.5 Pakistan Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.6 Bangladesh Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.7 Indonesia Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.8 Thailand Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.9 Singapore Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.10 Malaysia Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.11 Philippines Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.4.12 Vietnam Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.5.2 Colombia Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.5.3 Chile Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.5.4 Argentina Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.5.5 Venezuela Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.5.6 Peru Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.5.7 Puerto Rico Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.5.8 Ecuador Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.6.2 Kuwait Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.6.3 Oman Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.6.4 Qatar Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.6.5 Saudi Arabia Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.6.6 United Arab Emirates Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.7.2 South Africa Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.7.3 Egypt Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.7.4 Algeria Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Neoantigen Targeted Therapies Consumption (2017-2022)
-
10.8.2 New Zealand Neoantigen Targeted Therapies Consumption (2017-2022)
11 Global Neoantigen Targeted Therapies Competitive Analysis
-
11.1 Gradalis
-
11.1.1 Gradalis Company Details
-
11.1.2 Gradalis Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Gradalis Neoantigen Targeted Therapies Main Business and Markets Served
-
11.1.4 Gradalis Neoantigen Targeted Therapies Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Genocea Biosciences
-
11.2.1 Genocea Biosciences Company Details
-
11.2.2 Genocea Biosciences Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Genocea Biosciences Neoantigen Targeted Therapies Main Business and Markets Served
-
11.2.4 Genocea Biosciences Neoantigen Targeted Therapies Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Iovance Biotherapeutics
-
11.3.1 Iovance Biotherapeutics Company Details
-
11.3.2 Iovance Biotherapeutics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Main Business and Markets Served
-
11.3.4 Iovance Biotherapeutics Neoantigen Targeted Therapies Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Neon Therapeutics
-
11.4.1 Neon Therapeutics Company Details
-
11.4.2 Neon Therapeutics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Neon Therapeutics Neoantigen Targeted Therapies Main Business and Markets Served
-
11.4.4 Neon Therapeutics Neoantigen Targeted Therapies Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Immunicum
-
11.5.1 Immunicum Company Details
-
11.5.2 Immunicum Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Immunicum Neoantigen Targeted Therapies Main Business and Markets Served
-
11.5.4 Immunicum Neoantigen Targeted Therapies Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bavarian Nordic
-
11.6.1 Bavarian Nordic Company Details
-
11.6.2 Bavarian Nordic Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bavarian Nordic Neoantigen Targeted Therapies Main Business and Markets Served
-
11.6.4 Bavarian Nordic Neoantigen Targeted Therapies Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Precision Biologics
-
11.7.1 Precision Biologics Company Details
-
11.7.2 Precision Biologics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Precision Biologics Neoantigen Targeted Therapies Main Business and Markets Served
-
11.7.4 Precision Biologics Neoantigen Targeted Therapies Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Immunovative Therapies
-
11.8.1 Immunovative Therapies Company Details
-
11.8.2 Immunovative Therapies Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Immunovative Therapies Neoantigen Targeted Therapies Main Business and Markets Served
-
11.8.4 Immunovative Therapies Neoantigen Targeted Therapies Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Medigene
-
11.9.1 Medigene Company Details
-
11.9.2 Medigene Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Medigene Neoantigen Targeted Therapies Main Business and Markets Served
-
11.9.4 Medigene Neoantigen Targeted Therapies Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Vaxon Biotech
-
11.10.1 Vaxon Biotech Company Details
-
11.10.2 Vaxon Biotech Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Vaxon Biotech Neoantigen Targeted Therapies Main Business and Markets Served
-
11.10.4 Vaxon Biotech Neoantigen Targeted Therapies Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Neoantigen Targeted Therapies Market Outlook by Types and Applications to 2028
-
12.1 Global Neoantigen Targeted Therapies Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Neoantigen Targeted Therapies Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Medical Research Institution Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Hospital and Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Neoantigen Targeted Therapies Market Analysis and Outlook to 2028
-
13.1 Global Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.2.2 Canada Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.2.3 Mexico Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.2 UK Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.3 Spain Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.4 Belgium Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.5 France Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.6 Italy Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.7 Denmark Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.8 Finland Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.9 Norway Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.10 Sweden Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.11 Poland Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.12 Russia Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.3.13 Turkey Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.2 Japan Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.3 India Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.4 South Korea Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.8 Thailand Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.9 Singapore Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.11 Philippines Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.2 Colombia Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.3 Chile Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.4 Argentina Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.6 Peru Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.3 Oman Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.4 Qatar Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.7.2 South Africa Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.7.3 Egypt Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.7.4 Algeria Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Neoantigen Targeted Therapies
-
Figure of Neoantigen Targeted Therapies Picture
-
Table Global Neoantigen Targeted Therapies Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Neoantigen Targeted Therapies Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Monotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Research Institution Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital and Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Table North America Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Figure United States Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Canada Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Mexico Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Europe Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Figure Germany Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure UK Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Spain Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Belgium Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure France Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Italy Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Denmark Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Finland Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Norway Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Sweden Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Poland Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Russia Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Turkey Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table APAC Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Figure China Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Japan Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure India Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Thailand Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Singapore Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Philippines Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table South America Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Figure Brazil Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Colombia Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Chile Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Argentina Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Peru Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table GCC Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Figure Bahrain Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Oman Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Qatar Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Africa Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Figure Nigeria Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Africa Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Egypt Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Algeria Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Oceania Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Figure Australia Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Gradalis Company Details
-
Table Gradalis Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gradalis Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Gradalis Neoantigen Targeted Therapies Product Portfolio
-
Table Genocea Biosciences Company Details
-
Table Genocea Biosciences Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genocea Biosciences Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Genocea Biosciences Neoantigen Targeted Therapies Product Portfolio
-
Table Iovance Biotherapeutics Company Details
-
Table Iovance Biotherapeutics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iovance Biotherapeutics Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Iovance Biotherapeutics Neoantigen Targeted Therapies Product Portfolio
-
Table Neon Therapeutics Company Details
-
Table Neon Therapeutics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neon Therapeutics Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Neon Therapeutics Neoantigen Targeted Therapies Product Portfolio
-
Table Immunicum Company Details
-
Table Immunicum Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immunicum Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Immunicum Neoantigen Targeted Therapies Product Portfolio
-
Table Bavarian Nordic Company Details
-
Table Bavarian Nordic Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bavarian Nordic Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Bavarian Nordic Neoantigen Targeted Therapies Product Portfolio
-
Table Precision Biologics Company Details
-
Table Precision Biologics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Precision Biologics Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Precision Biologics Neoantigen Targeted Therapies Product Portfolio
-
Table Immunovative Therapies Company Details
-
Table Immunovative Therapies Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immunovative Therapies Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Immunovative Therapies Neoantigen Targeted Therapies Product Portfolio
-
Table Medigene Company Details
-
Table Medigene Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medigene Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Medigene Neoantigen Targeted Therapies Product Portfolio
-
Table Vaxon Biotech Company Details
-
Table Vaxon Biotech Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vaxon Biotech Neoantigen Targeted Therapies Main Business and Markets Served
-
Table Vaxon Biotech Neoantigen Targeted Therapies Product Portfolio
-
Figure Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Research Institution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital and Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Table North America Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure United States Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Germany Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure China Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Brazil Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure Australia Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
